Caris & Company Upgrades Colgate-Palmolive (CL) to Buy
More News related to CL
- Notable Mergers and Acquisitions of the Day 11/19: BX, AGU/CF, PRIM, CL
- Faber Said His Sources Don't See a Reckett/Colgate-Palmolive (CL) Merger
- Colgate-Palmolive (CL) Won't Comment to NYSE On Today's Unusual Market Activity
- Colgate-Palmolive (CL) options active as shares rally
- Colgate-Palmolive (CL) Moves Up On Reports Of Possible Takeover
Caris & Company upgrades Colgate-Palmolive (NYSE: CL) from Above Average to Buy with a $76 price target.
Colgate-Palmolive Company, together with its subsidiaries, engages in the manufacture and marketing of consumer products worldwide.
Related Categories
UpgradesStocks Mentioned
-0.83Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
